| 000 | 01786 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516225933.0 | ||
| 264 | 0 | _c20160225 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1475-2727 | ||
| 024 | 7 |
_a10.1017/S1368980014001591 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDos Reis, Lígia Cardoso | |
| 245 | 0 | 0 |
_aAnthropometry and body composition of vertically HIV-infected children and adolescents under therapy with and without protease inhibitors. _h[electronic resource] |
| 260 |
_bPublic health nutrition _cMay 2015 |
||
| 300 |
_a1255-61 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdiposity |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 |
_aBrazil _xepidemiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGrowth Disorders _xchemically induced |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aHospitals, Pediatric |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfectious Disease Transmission, Vertical |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOutpatient Clinics, Hospital |
| 650 | 0 | 4 |
_aOverweight _xchemically induced |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 |
_aThinness _xchemically induced |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _ade Carvalho Rondó, Patrícia Helen | |
| 700 | 1 | _ade Sousa Marques, Heloisa Helena | |
| 700 | 1 | _aJosé Segri, Neuber | |
| 773 | 0 |
_tPublic health nutrition _gvol. 18 _gno. 7 _gp. 1255-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S1368980014001591 _zAvailable from publisher's website |
| 999 |
_c24091267 _d24091267 |
||